1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bacterial Vaginosis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Rx 1.2.3 OTC 1.3 Market by Application 1.3.1 Global Bacterial Vaginosis Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Pharmacy 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Bacterial Vaginosis Drug Market Perspective (2016-2027) 2.2 Bacterial Vaginosis Drug Growth Trends by Regions 2.2.1 Bacterial Vaginosis Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Bacterial Vaginosis Drug Historic Market Share by Regions (2016-2021) 2.2.3 Bacterial Vaginosis Drug Forecasted Market Size by Regions (2022-2027) 2.3 Bacterial Vaginosis Drug Industry Dynamic 2.3.1 Bacterial Vaginosis Drug Market Trends 2.3.2 Bacterial Vaginosis Drug Market Drivers 2.3.3 Bacterial Vaginosis Drug Market Challenges 2.3.4 Bacterial Vaginosis Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Bacterial Vaginosis Drug Players by Revenue 3.1.1 Global Top Bacterial Vaginosis Drug Players by Revenue (2016-2021) 3.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Players (2016-2021) 3.2 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Bacterial Vaginosis Drug Revenue 3.4 Global Bacterial Vaginosis Drug Market Concentration Ratio 3.4.1 Global Bacterial Vaginosis Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Drug Revenue in 2020 3.5 Bacterial Vaginosis Drug Key Players Head office and Area Served 3.6 Key Players Bacterial Vaginosis Drug Product Solution and Service 3.7 Date of Enter into Bacterial Vaginosis Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Bacterial Vaginosis Drug Breakdown Data by Type 4.1 Global Bacterial Vaginosis Drug Historic Market Size by Type (2016-2021) 4.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2022-2027) 5 Bacterial Vaginosis Drug Breakdown Data by Application 5.1 Global Bacterial Vaginosis Drug Historic Market Size by Application (2016-2021) 5.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Bacterial Vaginosis Drug Market Size (2016-2027) 6.2 North America Bacterial Vaginosis Drug Market Size by Type 6.2.1 North America Bacterial Vaginosis Drug Market Size by Type (2016-2021) 6.2.2 North America Bacterial Vaginosis Drug Market Size by Type (2022-2027) 6.2.3 North America Bacterial Vaginosis Drug Market Size by Type (2016-2027) 6.3 North America Bacterial Vaginosis Drug Market Size by Application 6.3.1 North America Bacterial Vaginosis Drug Market Size by Application (2016-2021) 6.3.2 North America Bacterial Vaginosis Drug Market Size by Application (2022-2027) 6.3.3 North America Bacterial Vaginosis Drug Market Size by Application (2016-2027) 6.4 North America Bacterial Vaginosis Drug Market Size by Country 6.4.1 North America Bacterial Vaginosis Drug Market Size by Country (2016-2021) 6.4.2 North America Bacterial Vaginosis Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Bacterial Vaginosis Drug Market Size (2016-2027) 7.2 Europe Bacterial Vaginosis Drug Market Size by Type 7.2.1 Europe Bacterial Vaginosis Drug Market Size by Type (2016-2021) 7.2.2 Europe Bacterial Vaginosis Drug Market Size by Type (2022-2027) 7.2.3 Europe Bacterial Vaginosis Drug Market Size by Type (2016-2027) 7.3 Europe Bacterial Vaginosis Drug Market Size by Application 7.3.1 Europe Bacterial Vaginosis Drug Market Size by Application (2016-2021) 7.3.2 Europe Bacterial Vaginosis Drug Market Size by Application (2022-2027) 7.3.3 Europe Bacterial Vaginosis Drug Market Size by Application (2016-2027) 7.4 Europe Bacterial Vaginosis Drug Market Size by Country 7.4.1 Europe Bacterial Vaginosis Drug Market Size by Country (2016-2021) 7.4.2 Europe Bacterial Vaginosis Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Bacterial Vaginosis Drug Market Size (2016-2027) 8.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type 8.2.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application 8.3.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region 8.4.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Bacterial Vaginosis Drug Market Size (2016-2027) 9.2 Latin America Bacterial Vaginosis Drug Market Size by Type 9.2.1 Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2021) 9.2.2 Latin America Bacterial Vaginosis Drug Market Size by Type (2022-2027) 9.2.3 Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2027) 9.3 Latin America Bacterial Vaginosis Drug Market Size by Application 9.3.1 Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2021) 9.3.2 Latin America Bacterial Vaginosis Drug Market Size by Application (2022-2027) 9.3.3 Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2027) 9.4 Latin America Bacterial Vaginosis Drug Market Size by Country 9.4.1 Latin America Bacterial Vaginosis Drug Market Size by Country (2016-2021) 9.4.2 Latin America Bacterial Vaginosis Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Bacterial Vaginosis Drug Market Size (2016-2027) 10.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type 10.2.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application 10.3.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country 10.4.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer Bacterial Vaginosis Drug Introduction 11.1.4 Bayer Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.1.5 Bayer Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Bacterial Vaginosis Drug Introduction 11.2.4 Pfizer Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Bacterial Vaginosis Drug Introduction 11.3.4 Sanofi Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Piramal 11.4.1 Piramal Company Details 11.4.2 Piramal Business Overview 11.4.3 Piramal Bacterial Vaginosis Drug Introduction 11.4.4 Piramal Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.4.5 Piramal Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Abbott Business Overview 11.5.3 Abbott Bacterial Vaginosis Drug Introduction 11.5.4 Abbott Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.5.5 Abbott Recent Development 11.6 Galderma 11.6.1 Galderma Company Details 11.6.2 Galderma Business Overview 11.6.3 Galderma Bacterial Vaginosis Drug Introduction 11.6.4 Galderma Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.6.5 Galderma Recent Development 11.7 Mission 11.7.1 Mission Company Details 11.7.2 Mission Business Overview 11.7.3 Mission Bacterial Vaginosis Drug Introduction 11.7.4 Mission Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.7.5 Mission Recent Development 11.8 Alkem 11.8.1 Alkem Company Details 11.8.2 Alkem Business Overview 11.8.3 Alkem Bacterial Vaginosis Drug Introduction 11.8.4 Alkem Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.8.5 Alkem Recent Development 11.9 Xiuzheng 11.9.1 Xiuzheng Company Details 11.9.2 Xiuzheng Business Overview 11.9.3 Xiuzheng Bacterial Vaginosis Drug Introduction 11.9.4 Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.9.5 Xiuzheng Recent Development 11.10 Teva 11.10.1 Teva Company Details 11.10.2 Teva Business Overview 11.10.3 Teva Bacterial Vaginosis Drug Introduction 11.10.4 Teva Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.10.5 Teva Recent Development 11.11 Perrigo 11.11.1 Perrigo Company Details 11.11.2 Perrigo Business Overview 11.11.3 Perrigo Bacterial Vaginosis Drug Introduction 11.11.4 Perrigo Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.11.5 Perrigo Recent Development 11.12 West-Ward 11.12.1 West-Ward Company Details 11.12.2 West-Ward Business Overview 11.12.3 West-Ward Bacterial Vaginosis Drug Introduction 11.12.4 West-Ward Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.12.5 West-Ward Recent Development 11.13 HPGC 11.13.1 HPGC Company Details 11.13.2 HPGC Business Overview 11.13.3 HPGC Bacterial Vaginosis Drug Introduction 11.13.4 HPGC Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.13.5 HPGC Recent Development 11.14 Yunnan Baiyao 11.14.1 Yunnan Baiyao Company Details 11.14.2 Yunnan Baiyao Business Overview 11.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Introduction 11.14.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.14.5 Yunnan Baiyao Recent Development 11.15 Starpharma 11.15.1 Starpharma Company Details 11.15.2 Starpharma Business Overview 11.15.3 Starpharma Bacterial Vaginosis Drug Introduction 11.15.4 Starpharma Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.15.5 Starpharma Recent Development 11.16 Novel 11.16.1 Novel Company Details 11.16.2 Novel Business Overview 11.16.3 Novel Bacterial Vaginosis Drug Introduction 11.16.4 Novel Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.16.5 Novel Recent Development 11.17 Edenvridge 11.17.1 Edenvridge Company Details 11.17.2 Edenvridge Business Overview 11.17.3 Edenvridge Bacterial Vaginosis Drug Introduction 11.17.4 Edenvridge Revenue in Bacterial Vaginosis Drug Business (2016-2021) 11.17.5 Edenvridge Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Bacterial Vaginosis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Rx Table 3. Key Players of OTC Table 4. Global Bacterial Vaginosis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Bacterial Vaginosis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Bacterial Vaginosis Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Bacterial Vaginosis Drug Market Share by Regions (2016-2021) Table 8. Global Bacterial Vaginosis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Bacterial Vaginosis Drug Market Share by Regions (2022-2027) Table 10. Bacterial Vaginosis Drug Market Trends Table 11. Bacterial Vaginosis Drug Market Drivers Table 12. Bacterial Vaginosis Drug Market Challenges Table 13. Bacterial Vaginosis Drug Market Restraints Table 14. Global Bacterial Vaginosis Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Bacterial Vaginosis Drug Market Share by Players (2016-2021) Table 16. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2020) Table 17. Ranking of Global Top Bacterial Vaginosis Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Bacterial Vaginosis Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Bacterial Vaginosis Drug Product Solution and Service Table 21. Date of Enter into Bacterial Vaginosis Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2016-2021) Table 25. Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Bacterial Vaginosis Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2016-2021) Table 29. Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Bayer Company Details Table 62. Bayer Business Overview Table 63. Bayer Bacterial Vaginosis Drug Product Table 64. Bayer Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 65. Bayer Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Bacterial Vaginosis Drug Product Table 69. Pfizer Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 70. Pfizer Recent Development Table 71. Sanofi Company Details Table 72. Sanofi Business Overview Table 73. Sanofi Bacterial Vaginosis Drug Product Table 74. Sanofi Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 75. Sanofi Recent Development Table 76. Piramal Company Details Table 77. Piramal Business Overview Table 78. Piramal Bacterial Vaginosis Drug Product Table 79. Piramal Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 80. Piramal Recent Development Table 81. Abbott Company Details Table 82. Abbott Business Overview Table 83. Abbott Bacterial Vaginosis Drug Product Table 84. Abbott Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 85. Abbott Recent Development Table 86. Galderma Company Details Table 87. Galderma Business Overview Table 88. Galderma Bacterial Vaginosis Drug Product Table 89. Galderma Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 90. Galderma Recent Development Table 91. Mission Company Details Table 92. Mission Business Overview Table 93. Mission Bacterial Vaginosis Drug Product Table 94. Mission Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 95. Mission Recent Development Table 96. Alkem Company Details Table 97. Alkem Business Overview Table 98. Alkem Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 99. Alkem Recent Development Table 100. Xiuzheng Company Details Table 101. Xiuzheng Business Overview Table 102. Xiuzheng Bacterial Vaginosis Drug Product Table 103. Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 104. Xiuzheng Recent Development Table 105. Teva Company Details Table 106. Teva Business Overview Table 107. Teva Bacterial Vaginosis Drug Product Table 108. Teva Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 109. Teva Recent Development Table 110. Perrigo Company Details Table 111. Perrigo Business Overview Table 112. Perrigo Bacterial Vaginosis Drug Product Table 113. Perrigo Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 114. Perrigo Recent Development Table 115. West-Ward Company Details Table 116. West-Ward Business Overview Table 117. West-Ward Bacterial Vaginosis Drug Product Table 118. West-Ward Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 119. West-Ward Recent Development Table 120. HPGC Company Details Table 121. HPGC Business Overview Table 122. HPGC Bacterial Vaginosis Drug Product Table 123. HPGC Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 124. HPGC Recent Development Table 125. Yunnan Baiyao Company Details Table 126. Yunnan Baiyao Business Overview Table 127. Yunnan Baiyao Bacterial Vaginosis Drug Product Table 128. Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 129. Yunnan Baiyao Recent Development Table 130. Starpharma Company Details Table 131. Starpharma Business Overview Table 132. Starpharma Bacterial Vaginosis Drug Product Table 133. Starpharma Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 134. Starpharma Recent Development Table 135. Novel Company Details Table 136. Novel Business Overview Table 137. Novel Bacterial Vaginosis Drug Product Table 138. Novel Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 139. Novel Recent Development Table 140. Edenvridge Company Details Table 141. Edenvridge Business Overview Table 142. Edenvridge Bacterial Vaginosis Drug Product Table 143. Edenvridge Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million) Table 144. Edenvridge Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Bacterial Vaginosis Drug Market Share by Type: 2020 VS 2027 Figure 2. Rx Features Figure 3. OTC Features Figure 4. Global Bacterial Vaginosis Drug Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Pharmacy Case Studies Figure 7. Other Case Studies Figure 8. Bacterial Vaginosis Drug Report Years Considered Figure 9. Global Bacterial Vaginosis Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Bacterial Vaginosis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Bacterial Vaginosis Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Bacterial Vaginosis Drug Market Share by Regions (2022-2027) Figure 13. Global Bacterial Vaginosis Drug Market Share by Players in 2020 Figure 14. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Drug Revenue in 2020 Figure 16. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Bacterial Vaginosis Drug Market Share by Type (2016-2027) Figure 20. North America Bacterial Vaginosis Drug Market Share by Application (2016-2027) Figure 21. North America Bacterial Vaginosis Drug Market Share by Country (2016-2027) Figure 22. United States Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Bacterial Vaginosis Drug Market Share by Type (2016-2027) Figure 26. Europe Bacterial Vaginosis Drug Market Share by Application (2016-2027) Figure 27. Europe Bacterial Vaginosis Drug Market Share by Country (2016-2027) Figure 28. Germany Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Bacterial Vaginosis Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Bacterial Vaginosis Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Bacterial Vaginosis Drug Market Share by Region (2016-2027) Figure 38. China Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Bacterial Vaginosis Drug Market Share by Type (2016-2027) Figure 46. Latin America Bacterial Vaginosis Drug Market Share by Application (2016-2027) Figure 47. Latin America Bacterial Vaginosis Drug Market Share by Country (2016-2027) Figure 48. Mexico Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Bacterial Vaginosis Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Bacterial Vaginosis Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Bacterial Vaginosis Drug Market Share by Country (2016-2027) Figure 54. Turkey Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Bayer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 58. Pfizer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 59. Sanofi Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 60. Piramal Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 61. Abbott Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 62. Galderma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 63. Mission Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 64. Alkem Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 65. Xiuzheng Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 66. Teva Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 67. Perrigo Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 68. West-Ward Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 69. HPGC Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 70. Yunnan Baiyao Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 71. Starpharma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 72. Novel Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 73. Edenvridge Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Bayer Pfizer Sanofi Piramal Abbott Galderma Mission Alkem Xiuzheng Teva Perrigo West-Ward HPGC Yunnan Baiyao Starpharma Novel Edenvridge